Publications
- Monoclonal anti-endoglin antibody TRC105 (carotuximab) prevents hypercholesterolemia and hyperglycemia-induced endothelial dysfunction in human aortic endothelial cells2022 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts2020 | Faculty of Pharmacy in Hradec Králové
- Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro2019 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- MMP-12, Secreted by Pro-Inflammatory Macrophages, Targets Endoglin in Human Macrophages and Endothelial Cells2019 | Faculty of Pharmacy in Hradec Králové
- Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta2018 | Faculty of Pharmacy in Hradec Králové
- Soluble endoglin modulates the pro-inflammatory mediators NF-kappa B and IL-6 in cultured human endothelial cells2017 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
Loading network view...
